GL1X · GenesisL1 explorer

UniProt P09945

Hirudin variant-2 (P09945)

Hirudin variant-2 (UniProt P09945): 218 experimental structures and 1 predicted model on GenesisL1, 20 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P09945
Protein
Hirudin variant-2
Experimental structures
218
Predicted models
1
Pockets
20 · 19 records with a druggable one

Structures

219 records of P09945 in the MolNFT archive: 218 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1A2CStructure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGAx-ray diffractionI——
1A2CStructure of thrombin inhibited by AERUGINOSIN298-a from a blue-green algax-ray diffractionI——
1A46Thrombin complexed with hirugen and a beta-strand mimetic inhibitorx-ray diffractionI——
1A46Thrombin complexed with hirugen and a beta-strand mimetic inhibitorx-ray diffractionI——
1A4WCrystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding sitex-ray diffractionI——
1A4WCrystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding sitex-ray diffractionI——
1A5GHuman thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugenx-ray diffractionI——
1A5GHuman thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugenx-ray diffractionI——
1A61Thrombin complexed with a beta-mimetic thiazole-containing inhibitorx-ray diffractionI——
1A61Thrombin complexed with a beta-mimetic thiazole-containing inhibitorx-ray diffractionI——
1B5GHuman thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugenx-ray diffractionI——
1B5GHuman thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugenx-ray diffractionI——
1DOJCrystal structure of human alpha-thrombin*RWJ-51438 complex at 1.7 Ax-ray diffractionB——
1DOJCrystal structure of human alpha-THROMBIN*RWJ-51438 complex at 1.7 ax-ray diffractionB——
1HGTStructure of the hirugen and hirulog 1 complexes of alpha-thrombinx-ray diffractionI——
1HGTStructure of the hirugen and hirulog 1 complexes of alpha- thrombinx-ray diffractionI——
1K21Human thrombin-inhibitor complexx-ray diffractionI——
1K21Human thrombin-inhibitor complexx-ray diffractionI——
1K22Human thrombin-inhibitor complexx-ray diffractionI——
1K22Human thrombin-inhibitor complexx-ray diffractionI——
1NRSCrystallographic structures of thrombin complexed with thrombin receptor peptides: existence of…x-ray diffractionI——
1NRSCrystallographic structures of thrombin complexed with thrombin receptor peptides: existence of…x-ray diffractionI——
1TBZHuman thrombin with active site N-methyl-D phenylalanyl-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZ…x-ray diffractionI——
1TBZHuman thrombin with active site N-methyl-D phenylalanyl-N-[5…x-ray diffractionI——
1TMBMolecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide…x-ray diffractionI——
1TMBMolecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide…x-ray diffractionI——
1TMUChanges in interactions in complexes of hirudin derivatives and human alpha-thrombin due to…x-ray diffractionJ——
1TMUChanges in interactions in complexes of hirudin derivatives and human alpha-thrombin due to…x-ray diffractionJ——
1VZQComplex of thrombin with designed inhibitor 7165x-ray diffractionI——
1VZQComplex of thrombin with designed inhibitor 7165x-ray diffractionI——
1W7GAlpha-thrombin complex with sulfated hirudin (residues 54-65) and L- Arginine template inhibitor…x-ray diffractionI——
1W7GAlpha-thrombin complex with sulfated hirudin (residues 54-65) and L- arginine template inhibitor…x-ray diffractionI——
1WBGActive site thrombin inhibitorsx-ray diffractionI——
1WBGActive site thrombin inhibitorsx-ray diffractionI——
2BVRHuman thrombin complexed with fragment-based small molecules occupying the S1 pocketx-ray diffractionI——
2BVRHuman thrombin complexed with fragment-based small molecules occupying the S1 pocketx-ray diffractionI——
2BVSHuman thrombin complexed with fragment-based small molecules occupying the S1 pocketx-ray diffractionI——
2BVSHuman thrombin complexed with fragment-based small molecules occupying the S1 pocketx-ray diffractionI——
2BVXDesign and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linkerx-ray diffractionI——
2BVXDesign and discovery of novel, potent thrombin inhibitors with a solubilizing cationic P1-P2-linkerx-ray diffractionI——
2BXTDesign and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linkerx-ray diffractionI——
2BXTDesign and discovery of novel, potent thrombin inhibitors with a solubilizing cationic P1-P2-linkerx-ray diffractionI——
2BXUDesign and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linkerx-ray diffractionI——
2BXUDesign and discovery of novel, potent thrombin inhibitors with a solubilizing cationic P1-P2-linkerx-ray diffractionI——
2C8Wthrombin inhibitorsx-ray diffractionI——
2C8WThrombin inhibitorsx-ray diffractionI——
2C8Xthrombin inhibitorsx-ray diffractionI——
2C8XThrombin inhibitorsx-ray diffractionI——
2C8Ythrombin inhibitorsx-ray diffractionI——
2C8YThrombin inhibitorsx-ray diffractionI——
2C8Zthrombin inhibitorsx-ray diffractionI——
2C8ZThrombin inhibitorsx-ray diffractionI——
2C90thrombin inhibitorsx-ray diffractionI——
2C90Thrombin inhibitorsx-ray diffractionI——
2C93thrombin inhibitorsx-ray diffractionI——
2C93Thrombin inhibitorsx-ray diffractionI——
2ZFQExploring thrombin S3 pocketx-ray diffractionI——
2ZFQExploring thrombin S3 pocketx-ray diffractionI——
2ZFRExploring thrombin S3 pocketx-ray diffractionI——
2ZFRExploring thrombin S3 pocketx-ray diffractionI——

159 records more on the page itself.

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.